Soligenix Inc (SNGX)
0.39
+0.03
(+7.29%)
USD |
NASDAQ |
May 16, 16:00
0.39
0.00 (0.00%)
After-Hours: 20:00
Soligenix Enterprise Value: 2.066M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 2.066M |
| May 15, 2024 | 1.648M |
| May 14, 2024 | 2.065M |
| May 13, 2024 | 2.066M |
| May 10, 2024 | 2.207M |
| May 09, 2024 | 2.319M |
| May 08, 2024 | 2.351M |
| May 07, 2024 | 2.237M |
| May 06, 2024 | 2.411M |
| May 03, 2024 | 2.296M |
| May 02, 2024 | 1.665M |
| May 01, 2024 | 1.544M |
| April 30, 2024 | 1.459M |
| April 29, 2024 | 1.801M |
| April 26, 2024 | 1.815M |
| April 25, 2024 | 1.986M |
| April 24, 2024 | 1.359M |
| April 23, 2024 | 1.601M |
| April 22, 2024 | 1.684M |
| April 19, 2024 | 0.6313M |
| April 18, 2024 | 0.6784M |
| April 17, 2024 | 1.498M |
| April 16, 2024 | 1.081M |
| April 15, 2024 | 1.059M |
| April 12, 2024 | -0.0319M |
| Date | Value |
|---|---|
| April 11, 2024 | -0.0046M |
| April 10, 2024 | 0.7774M |
| April 09, 2024 | 0.7995M |
| April 08, 2024 | 1.004M |
| April 05, 2024 | 0.8668M |
| April 04, 2024 | 0.8521M |
| April 03, 2024 | 1.011M |
| April 02, 2024 | 1.588M |
| April 01, 2024 | 1.798M |
| March 31, 2024 | 2.219M |
| March 28, 2024 | 1.129M |
| March 27, 2024 | 1.204M |
| March 26, 2024 | 1.024M |
| March 25, 2024 | 1.340M |
| March 22, 2024 | 1.496M |
| March 21, 2024 | 1.550M |
| March 20, 2024 | 1.396M |
| March 19, 2024 | 1.350M |
| March 18, 2024 | 1.235M |
| March 15, 2024 | 1.340M |
| March 14, 2024 | 1.517M |
| March 13, 2024 | 2.243M |
| March 12, 2024 | 2.287M |
| March 11, 2024 | 2.567M |
| March 08, 2024 | 2.885M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-6.008M
Minimum
Sep 01 2023
71.15M
Maximum
Dec 17 2020
20.11M
Average
16.70M
Median
Enterprise Value Benchmarks
| Eagle Pharmaceuticals Inc | -- |
| Marinus Pharmaceuticals Inc | 31.63M |
| NovaBay Pharmaceuticals Inc | 5.209M |
| Palatin Technologies Inc | 23.43M |
| iBio Inc | 16.17M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.915M |
| Revenue (Quarterly) | 0.117M |
| Total Expenses (Quarterly) | 2.111M |
| EPS Diluted (Quarterly) | -0.18 |
| Profit Margin (Quarterly) | -1.64K% |
| Earnings Yield | -184.6% |
| Normalized Earnings Yield | -185.93 |